Projected public health benefits of a hypothetical HSV-1 vaccine in the United States: A mathematical modeling analysis
Science Advances · 05.06.2026 · 12 (23)
DOI: 10.1126/sciadv.aee0698 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 05.06.2026. Verfasst von Bechir S Naffeti und 3 weiteren Autor:innen. Beteiligte Einrichtung: Mathematics Program, Department of Mathematics and Statistics, College of Arts and Sciences, Qatar University, Doha, Qatar. Hauptthemen laut MEDLINE: Herpesvirus 1, Human, Models, Theoretical, Herpes Simplex Virus Vaccines, Public Health. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Qatar Research Development and Innovation Council.
Abstract (Originalsprache)
Herpes simplex virus type 1 (HSV-1) infection is highly prevalent worldwide and causes oral, genital, and neonatal herpes. Several HSV vaccine candidates are currently in development. This study used mathematical modeling to estimate the potential population-level impact of HSV-1 vaccination strategies in the United States. Infant vaccination with 70% efficacy and lifelong protection introduced in 2030 reduced oral and genital incidence rate by 47.3 and 58.3% by 2075, respectively, with annual new infections declining by 41.2 and 53.5%, corresponding to 28.5 million cumulative infections averted. The number needed to vaccinate to prevent one infection, defined from program initiation to a specified year, declined from 35.8 by 2040 to 7.2 by 2070. Addition of adolescent catch-up vaccination further reduced oral and particularly genital incidence. Lifelong protection produced approximately threefold greater impact than 15-year protection. HSV-1 vaccination could substantially reduce oral and genital HSV-1 burden, supporting prioritization of vaccine development and integration into public health strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Mathematics Program, Department of Mathematics and Statistics, College of Arts and Sciences, Qatar University, Doha, Qatar.
- Department of Medicine, Division of Allergy and Infectious Diseases and Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
- Vaccine and Infectious Diseases Division, Fred Hutch Cancer Center, Seattle, WA, USA.
- Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
- Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA.
- Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
ORCID-Profile: Bechir S Naffeti, Houssein H Ayoub, Christine Johnston, Laith J Abu-Raddad
Förderung
- Qatar Research Development and Innovation Council
Zitieren
APA
Naffeti, B. S., Ayoub, H. H., Johnston, C., & Abu-Raddad, L. J. (2026). Projected public health benefits of a hypothetical HSV-1 vaccine in the United States: A mathematical modeling analysis. Science Advances, 12(23). https://doi.org/10.1126/sciadv.aee0698
Vancouver
Naffeti BS, Ayoub HH, Johnston C, Abu-Raddad LJ. Projected public health benefits of a hypothetical HSV-1 vaccine in the United States: A mathematical modeling analysis. Science Advances. 2026;12(23). doi:10.1126/sciadv.aee0698
BibTeX
@article{Naffeti2026,
author = {Naffeti, Bechir S and Ayoub, Houssein H and Johnston, Christine and Abu-Raddad, Laith J},
title = {Projected public health benefits of a hypothetical HSV-1 vaccine in the United States: A mathematical modeling analysis},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {23},
doi = {10.1126/sciadv.aee0698}
}
EUVIMED